MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 216 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,347,694 | -43.0% | 19,088 | -45.7% | 0.02% | -44.4% |
Q1 2024 | $9,389,393 | +22.8% | 35,161 | +6.4% | 0.03% | +3.8% |
Q4 2023 | $7,644,795 | +189.0% | 33,040 | +82.4% | 0.03% | +160.0% |
Q3 2023 | $2,645,369 | -3.2% | 18,114 | +53.2% | 0.01% | -9.1% |
Q2 2023 | $2,731,575 | +111666.6% | 11,825 | +17.2% | 0.01% | 0.0% |
Q1 2023 | $2,444 | – | 10,090 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |